BridgeMD
New treatment option for Breast Cancer
Official title Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
ClinicalTrials.gov ID: NCT05056350
What this study is testing
- What it's testing
- The diagnosis of breast cancer and the treatments implemented have a significant impact on the professional situation. Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Age ≥18 years
- Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or...
- Patient who has completed adjuvant treatment, except for hormonotherapy
- Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis
- Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field
You likely can't join if
- Metastatic breast cancer or any other cancer within the last 5 years
- Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy)
- Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a...
- Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test)
- Physical inability to answer questionnaires
See the full eligibility criteria
- Age ≥18 years
- Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or chemotherapy)
- Patient who has completed adjuvant treatment, except for hormonotherapy
- Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis
- Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field
- Patient wishing to be accompanied for an adapted return to her current job or for a return to a new more adapted job
- Patient who signed the informed consent after informed information by her clinician
- Metastatic breast cancer or any other cancer within the last 5 years
- Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy)
- Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorder...
- Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test)
- Physical inability to answer questionnaires
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.